Neuroscience

Month

January 2013

Jan 30, 2013181 notes
#science #brain #brain cells #fruit fly #neuron #neuron activity #memory #learning #temperature #dopaminergic neurons #neuroscience
Jan 29, 2013454 notes
#science #exoskeleton #robots #robotics #bionic limbs #prosthetics
Jan 29, 201347 notes
#hearing #hearing loss #proteins #LINC #mutations #genes #genetics #neuroscience #science
Jan 29, 201359 notes
#vision #blindness #retinitis pigmentosa #retinal degeneration #stem cells #retina #neuroscience #science
Jan 29, 2013313 notes
#brain #language #Paul Broca #broca's area #Louis Leborgne #epilepsy #neuroscience #psychology #science
Jan 29, 201335 notes
#brain #brain activity #vegetative state #fMRI #brain hemorrhage #Ariel Sharon #neuroscience #science
Protein Family Linked to Autism Suppresses the Development of Inhibitory Synapses

Synapse development is promoted by a variety of cell adhesion molecules that connect neurons and organize synaptic proteins. Many of these adhesion molecules are linked to neurodevelopmental disorders; mutations in neuroligin and neurexin proteins, for example, are associated with autism and schizophrenia. According to a study in The Journal of Cell Biology, another family of proteins linked to these disorders regulates the function of neuroligins and neurexins in order to suppress the development of inhibitory synapses.

Like neurexins and neuroligins, the neuronal proteins MDGA1 and MDGA2 have been linked to autism and schizophrenia, but their function in neurodevelopment was unknown. Both MDGA proteins localize to the plasma membrane, and their extracellular domains are similar to those of cell adhesion molecules. On the other hand, postsynaptic neuroligin proteins are known to help synapses form by associating with neurexins on presynaptic membranes. Neuroligin-2 specifically boosts the development of inhibitory synapses, whereas neuroligin-1 promotes the development of excitatory synapses.

Ann Marie Craig and colleagues from the University of British Columbia investigated the function of MDGAs using co-culture assays, in which postsynaptic proteins like neuroligin-1 or -2 are expressed in non-neuronal cells and then tested for their ability to induce presynaptic differentiation in neighboring neurons. MDGA1 didn’t promote synapse formation in these assays. Instead, it inhibited the ability of neuroligin-2 to promote synapse development. The researchers found that MDGA1’s extracellular domains bound to neuroligin-2, blocking its association with neurexin. The same domains were sufficient to inhibit neuroligin-2’s synapse-promoting activity. In contrast, MDGA1 didn’t show high affinity binding to, or inhibit the function of, neuroligin-1. This suggested that, by inhibiting neuroligin-2, MDGA1 might specifically suppress the development of inhibitory synapses, so Craig and colleagues investigated MDGA1 function in cultured hippocampal neurons.

“Overexpressing MDGA1 in neurons reduced the density of inhibitory synapses without affecting excitatory synapses,” Craig says. Knocking down MDGA1, on the other hand, increased inhibitory synapse development but had no effect on excitatory synapses.

“I can’t think of any other proteins that specifically suppress inhibitory synapse formation,” says Craig. Indeed, very few proteins in general have been identified as negative regulators of synapse development, compared to the many proteins that are known to promote synaptogenesis. The results suggest that function-altering mutations in the MDGA proteins may disrupt the balance of excitatory and inhibitory synapses in the brain, potentially explaining the development of autism and other neurodevelopmental disorders.

“This puts MDGAs in the same pathway as neurexins and neuroligins and strengthens the evidence for the involvement of synaptic organizing proteins in autism and schizophrenia,” Craig explains. As well as investigating the function of MDGA2, the researchers want to explore the therapeutic potential of MDGA1 inhibitors, not only against autism and schizophrenia but also for the treatment of epilepsy, in which excitatory and inhibitory synapses are also imbalanced.

(Source)

Jan 29, 201347 notes
#autism #schizophrenia #synapses #neurexin #neuron #mutations #inhibitory synapses #neuroscience #science
Cardiac Disease Linked to Higher Risk of Mental Impairment

Cardiac disease is associated with increased risk of mild cognitive impairment such as problems with language, thinking and judgment — particularly among women with heart disease, a Mayo Clinic study shows. Known as nonamnestic because it doesn’t include memory loss, this type of mild cognitive impairment may be a precursor to vascular and other non-Alzheimer’s dementias, according to the findings published online Monday in JAMA Neurology.

Mild cognitive impairment is an important stage for early detection and intervention in dementia, says lead author, Rosebud Roberts, M.B., Ch.B., a health sciences researcher at Mayo Clinic.

"Prevention and management of cardiac disease and vascular risk factors are likely to reduce the risk," Roberts says.

Researchers evaluated 2,719 people ages 70 to 89 at the beginning of the study and every 15 months after. Of the 1,450 without mild cognitive impairment at the beginning, 669 had heart disease and 59 (8.8 percent) developed nonamenestic mild cognitive impairment; in comparison 34 (4.4 percent) of 781 who did not have heart disease developed nonamenestic mild cognitive impairment.

The association varied by sex; cardiac disease and mild cognitive impairment appeared together more often among women than in men.

(Source)

Jan 29, 201334 notes
#cognitive impairment #cardiac disease #memory loss #dementia #alzheimer's disease #neuroscience #science
Jan 29, 2013213 notes
#science #frontal cortex #orbitofrontal cortex #brain activity #addiction #decision-making #neuroimaging #neuroscience
Jan 29, 201379 notes
#brain #insulin #obesity #ventral tegmental area #satiety #neuroscience #psychology #science
Jan 29, 201388 notes
#schwann cells #nerve damage #nerve tissue #neuron #cells #myelin sheath #neuroscience #science
Jan 29, 2013161 notes
#amygdala #fear #fear response #memory #neuroscience #psychology #science
Jan 28, 201354 notes
#brain #mediterranean diet #health #nutrition #cognitive performance #cognitive function #science
Jan 28, 2013331 notes
#brain #brainbow #neuron #hippocampus #cerebellum #cortex #brain stem #neuroscience #science
Jan 28, 2013190 notes
#brainwaves #sleep #memory #prefrontal cortex #frontal lobe #aging #neuroscience #science
Jan 27, 201370 notes
#photoreceptors #retina #retinal degeneration #congenital blindness #gene therapy #science
Jan 27, 2013151 notes
#schizophrenia #mental illness #mental health #mutation #genetics #neuroscience #science
Jan 27, 201357 notes
#cell division #chromosomes #fruit fly #kinetochores #trisomy #mitosis #cells #science
Jan 27, 201332 notes
#PTSD #stress #stroke #treatment #medications #psychology #neuroscience #science
Jan 27, 201397 notes
#social aversion #corticosterone #stress #aggression #neurotransmitters #dopamine #neuroscience #science
Jan 26, 2013219 notes
#epigenetics #genes #inheritance #DNA #primordial gene cells #DNA methylation #science
Jan 26, 2013167 notes
#meditation #yoga #psychiatric disorders #mental illness #depression #science
Jan 26, 2013221 notes
#MRI #Sivu #music #science
Jan 26, 201374 notes
#migraines #headache #lightning #thunderstorm #weather #brain #serotonin #science
Jan 26, 201378 notes
#deep brain stimulation #autism #electrical stimulation #amygdala #neuroscience #science
Jan 25, 201373 notes
#autism #inflammation #CNS #fetus development #pregnancy #science
Jan 25, 2013156 notes
#anorexia nervosa #body perception #MRI #fusiform body area #extrastriate body area #neuroscience #science
Jan 25, 201358 notes
#science #brain #brain tumors #meningioma #genomics #genetics #neuroscience
Jan 25, 201370 notes
#science #brain cells #brain development #glial cells #stem cells #blood vessels #neuroscience
Jan 25, 201365 notes
#brain #brain activity #EEG #TOBI project #motor impairment #stroke #neuroscience #science
Jan 25, 201396 notes
#epilepsy #epileptic seizures #animal model #temporal lobe epilepsy #neuroscience #science
Jan 25, 201384 notes
#brain development #cerebral cortex #epilepsy #cancer #virus #neuroscience #science
Jan 25, 201382 notes
#brain activity #EEG #vegetative state #statistical results #neuroscience #science
Jan 24, 2013132 notes
#children #thinking #analytical thinking #executive function #psychology #neuroscience #science
Jan 24, 2013326 notes
#science #education #synesthesia #synesthetic association #memory #learning #psychology
Jan 24, 2013194 notes
#brain #proteins #smell #major histocompatibility complex #human cells #immune system #science
Jan 24, 201379 notes
#brain #brain injury #brain tissue #oxygen #hyperbaric oxygen therapy #neuroscience #science
Right target, but missing the bulls-eye for Alzheimer's

Alzheimer’s disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as amyloid-beta, or Abeta, which clumps together in the brain, forming plaques that are thought to destroy neurons. This destruction starts early, too, and can presage clinical signs of the disease by up to 20 years.

For decades now, researchers have been trying, with limited success, to develop drugs that prevent this clumping. Such drugs require a “target” — a structure they can bind to, thereby preventing the toxic actions of Abeta.

Now, a new study out of UCLA suggests that while researchers may have the right target in Abeta, they may be missing the bull’s-eye. Reporting in the Jan. 23 issue of the Journal of Molecular Biology, UCLA neurology professor David Teplow and colleagues focused on a particular segment of a toxic form of Abeta and discovered a unique hairpin-like structure that facilitates clumping.

"Every 68 seconds, someone in this country is diagnosed with Alzheimer’s," said Teplow, the study’s senior author and principal investigator of the NIH-sponsored Alzheimer’s Disease Research Center at UCLA. "Alzheimer’s disease is the only one of the top 10 causes of death in America that cannot be prevented, cured or even slowed down once it begins. Most of the drugs that have been developed have either failed or only provide modest improvement of the symptoms. So finding a better pathway for these potential therapeutics is critical."

The Abeta protein is composed of a sequence of amino acids, much like “a pearl necklace composed of 20 different combinations of different colors of pearl,” Teplow said. One form of Abeta, Abeta40, has 40 amino acids, while a second form, Abeta42, has two extra amino acids at one end.

Abeta42 has long been thought to be the toxic form of Abeta, but until now, no one has understood how the simple addition of two amino acids made it so much more toxic than Abeta40.

In his lab, Teplow and his colleagues used computer simulations in which they looked at the structure of the Abeta proteins in a virtual world. The researchers first created a virtual Abeta peptide that only contained the last 12 amino acids of the entire 42–amino-acid-long Abeta42 protein. Then, said Teplow, “we just let the molecule move around in a virtual world, letting the laws of physics determine how each atom of the peptide was attracted to or repulsed by other atoms.”

By taking thousands of snapshots of the various molecular structures the peptides created, the researchers determined which structures formed more frequently than others. From those, they then physically created mutant Abeta peptides using chemical synthesis.

"We studied these mutant peptides and found that the structure that made Abeta42 Abeta42 was a hairpin-like turn at the very end of the peptide of the whole Abeta protein," Teplow said.

The hairpin turn structure was not previously known in the detail revealed by the researchers, “so we feel our experiments were novel,” he said. “Our lab is the first to show that it is this specific turn that accounts for the special ability of Abeta42 to aggregate into clumps that we think kills neurons. Abeta40, the Abeta protein with two less amino acids at the end of the protein, did not do the same thing.”

Hopefully, the work of the Teplow laboratory presents what may the most relevant target yet for the development of drugs to fight Alzheimer’s disease, the researchers said.

Jan 24, 201338 notes
#alzheimer's disease #proteins #drug development #amyloid-beta #science
Jan 24, 201334 notes
#brain #nerve cells #primary visual cortex #memory #acetylcholine #neuroscience #science
Jan 24, 201339 notes
#nerve cells #brain cells #motor neurons #whiskers #neuroscience #science
Jan 24, 201394 notes
#social isolation #addiction #brain activity #neuron #adolescence #neuroscience #science
Jan 24, 2013233 notes
#brain cells #neuronal activity #sleep deprivation #depression #astrocytes #neuroscience #science
Jan 24, 2013112 notes
#retinal degeneration #blindness #photoreceptors #eye cells #neuroscience #science
Jan 23, 201369 notes
#3D vision #stereopsis #perception #depth perception #mathematical model #neuroscience #science
Jan 23, 201391 notes
#brain #implants #Auditory Brainstem Implant #prosthetics #hearing device #deafness #science
A brain protein called vimentin can indicate damage to the hippocampus following binge drinking

Chronic drinking is known to have detrimental health effects such as cardiac and liver problems, cognitive impairments, and brain damage. Binge drinking in particular is known to increase the risk of developing dementia and/or brain damage, yet little is known about an exact threshold for the damaging effects of alcohol. A study using rodents to examine various markers of neurodegeneration has found that brain damage can occur with as little as 24 hours of binge-like alcohol exposure.

Results will be published in the March 2013 issue of Alcoholism: Clinical & Experimental Research and are currently available at Early View.

"We know that the extent of damage following alcohol exposure depends heavily on the manner in which it is consumed," said Kimberly Nixon, associate professor of pharmaceutical sciences at The University of Kentucky as well as corresponding author for the study. "Human studies suggest that binge-pattern drinking is more closely associated with brain damage. One study, for example, reported that binge drinking at least once per month in adulthood significantly increases the risk of developing dementia later in life. Animal models help provide the critical information that binge drinking, which produces high blood alcohol levels, directly causes damage."

"The exact threshold for the damaging effects of alcohol on the brain is unclear," commented Fulton T. Crews, John Andrews Distinguished Professor and director of the Center for Alcohol Studies at the University of North Carolina. "It is likely that the higher the blood alcohol level the greater the damage, however, this manuscript only studies binge drinking, using vimentin and flurojade B as markers of neurotoxicity."

"People hear from multiple sources that low-moderate alcohol consumption can be beneficial, and then we come along and say that heavy alcohol use leads to detrimental outcomes," said Nixon. "People then want to know what the line is between beneficial and detrimental Unfortunately, we don’t know exactly. However, our study suggests that it may be even less than previously thought."

Nixon and her colleagues administered a nutritionally complete liquid diet to adult male Sprague-Dawley rats that additionally contained either alcohol (25% w/v) or isocaloric dextrose every eight hours for either one or two days. The rodents were sacrificed immediately following, two days after, or seven days after alcohol exposure and their brain tissues were examined.

"This was really a simple study that took advantage of some new ‘tools’ to look for evidence of brain damage," explained Nixon. "In other words, we didn’t look for dying cells themselves, but we looked at more indirect indices of damage by looking at what happens to astroglia, one of the ‘supporting’ cells for neurons. Astroglia react to brain damage by expressing several proteins that they do not normally express under healthy, happy conditions, one of which is an intermediate filament protein called vimentin. We saw a remarkable number of cells expressing this marker It is one of those ‘here is your brain, here is your brain on drugs’ kind of findings where the expression was obvious to the naked eye in many brains with as little as 24 hours of high blood alcohol levels."

Nixon added that, because rodents metabolize alcohol significantly faster than humans do, it is important to look at the actual concentration of alcohol in the blood in order to translate this to the human condition. “These rats had blood alcohol levels that were more than four times the legal driving limit, which for humans would require excessive drinking in the nature of a 12-pack of beer, a couple bottles of wine, or half of fifth of whisky. Unfortunately, drinking self-reports and blood alcohol level data from emergency rooms confirm that this level of drinking is common in those with alcohol use disorders.”

"Rodent brain damage can model human damage," noted Crews. "Vimentin seems to be a good marker of glial activation that shows that one day of binge drinking can cause some brain damage that persists and grows after a week of abstinence. However, both rodent and human brain damage generally require long-term alcohol consumption that models alcoholism and not the acute responses studied in this manuscript."

Nixon agreed. “The lack of overt neuronal deterioration suggests that a single, short-term, high-level binge probably does not result in functional changes and/or cognitive deficits,” she said. “However, since alcoholics experience multiple binges throughout their lifetime, it is important to consider that each successive binge, starting with the very first one, affords some level of damage to the brain. Therefore, theoretically, with multiple binges comes a cumulative detrimental effect where pronounced cognitive, behavioral, and structural effects are observed.”

Nixon said this study demonstrates that new discoveries are always possible. “You have to know where and when to look for some of these effects,” she said. “The reason why this discovery wasn’t made previously is merely due to groups, ourselves included, not taking the time to thoroughly investigate these lower threshold doses with some pretty specific time points. Chasing down a threshold is not a sexy topic and it was actually fairly risky in that it was possible that we would have had all negative effects. Nonetheless, the take-home message of our data is that even one short-duration binge-alcohol experience – which is unfortunately similar to what young adults may experience during spring break or weekend partying - may start a cascade that leads to brain damage.”

Jan 23, 201368 notes
#alcohol #binge drinking #brain #cognitive impairment #brain damage #vimentin #science
Jan 23, 201368 notes
#alcohol #sleep #REM sleep #brain activity #memory #depression #science
Jan 23, 201377 notes
#brain #cerebellum #hippocampus #neuroimaging #language #science
Jan 23, 201357 notes
#muscular dystrophy #dystrophin gene #muscle tissue #genetic mutation #genetics #science
Jan 23, 201377 notes
#circadian rhythms #biological clock #energy metabolism #health #science
Next page →
20132014
  • January
  • February
  • March
  • April
  • May
  • June
  • July
  • August
  • September
  • October
  • November
  • December
201220132014
  • January
  • February
  • March
  • April
  • May
  • June
  • July
  • August
  • September
  • October
  • November
  • December
20122013
  • January
  • February
  • March
  • April
  • May
  • June
  • July
  • August
  • September
  • October
  • November
  • December